# Home Care M&A Advisory Services for First-Time Sellers: How Hendon Partners Maximizes Your Exit > Selling your home care agency is the most important financial decision of your career — and you only get one chance to do it right. Here is how specialized M&A advisory transforms first-time-seller outcomes. Source: https://www.hendonpartners.com/insights/home-care-ma-advisory-services-first-time-sellers Author: Neli Gertner Published: 2026-05-04 Category: Seller Guides Tags: advisory, sell, M&A, first-time-seller, home-care, valuation ---Selling your home care agency is the largest, most complex, and most consequential financial transaction of your career. For most owners, it is also the only one they will ever do. The buyers across the table will have closed dozens — sometimes hundreds — of acquisitions. They have institutional playbooks, dedicated diligence teams, and incentives to acquire your business at the lowest defensible price. You will run this process once. That asymmetry is exactly what specialized **home care M&A advisory services** exist to neutralize. This guide explains how Hendon Partners' sell-side advisory model, buyer network, and value-maximization approach work — and why first-time sellers of mid-sized home care, home health, and hospice agencies consistently achieve materially better outcomes when represented. --- ## Why First-Time Sellers Need a Specialized M&A Advisor Generalist business brokers and regional accountants regularly offer to represent home care owners in a sale. They are not equipped for this market. **Selling a home care agency** is a specialized, regulated, payer-driven transaction that does not resemble selling a manufacturing business, a restaurant, or a professional services firm. A specialized **M&A advisor for mid-sized home care businesses** brings four things a generalist cannot: 1. **Buyer relationships.** Active dialogue with the private equity platforms, strategic operators, and national consolidators that actually buy home-based care agencies — and knowledge of which buyer is likely to pay the most for which type of business. 2. **Valuation fluency.** Deep familiarity with how home care, home health, hospice, IDD, behavioral health, and pediatric agencies are valued — including payer mix adjustments, EBITDA add-backs, working capital pegs, and current multiple ranges. 3. **Regulatory knowledge.** Understanding of CMS rules, the 80/20 Medicaid rule, CON requirements, CHOW timing, state licensing, and how each affects deal structure and certainty to close. 4. **Process discipline.** A repeatable sell-side process that creates buyer competition, manages diligence pressure, and protects the seller from the late-stage retrades that erode unrepresented deals. Without those four ingredients, a first-time seller is reacting to a buyer's process. With them, the seller is running their own. --- ## The Hidden Cost of Going Direct Most first-time sellers receive an unsolicited inbound from a buyer — often a private equity-backed platform — and assume that responding to it is the easiest path. It is rarely the most lucrative one. Across the home care M&A market, single-buyer, unrepresented sales typically clear at **20–40% lower enterprise value** than the same business sold through a competitive, advised process. The reasons are mechanical, not theoretical: - **No anchor.** With one buyer, there is no second offer to anchor against. The buyer sets the valuation conversation. - **No leverage in diligence.** A single buyer can retrade price during due diligence with no consequences. In a competitive process, the threat of an alternative buyer is real. - **Worse deal structure.** Unrepresented sellers commonly accept aggressive earnouts, undersized working capital pegs, longer escrow holds, and one-sided indemnification language they would never have agreed to with advisor pushback. - **Surprises.** Quality of Earnings reviews routinely produce a normalized EBITDA different from the seller's view. Advisors reconcile this in advance; unrepresented sellers absorb it as a price reduction. These are not edge cases. They are the predictable outcome of negotiating against a more experienced counterparty without representation. --- ## How Hendon Partners' Sell-Side Process Works Hendon Partners is a **sell-side only** **home care M&A advisory** firm. We do not represent buyers. We do not earn commissions from buyer-side relationships. Our economic alignment is entirely with the seller and the outcome of the transaction. Our process is designed for one thing: **maximizing home care agency sale value** while preserving certainty to close. ### Phase 1 — Preparation and Positioning (4–8 weeks) Before a single buyer is contacted, we spend the first phase building the foundation that determines outcome. - **EBITDA normalization** with full add-back documentation a Quality of Earnings team will defend - **Confidential Information Memorandum (CIM)** that positions the business in its most accurate and compelling light - **Three-statement financial model** buyers can underwrite directly - **Buyer list construction** matched to your service line, geography, and EBITDA size - **Management presentation prep** including mock buyer Q&A Most sellers underestimate this phase. It is where the largest valuation gains are unlocked. ### Phase 2 — Competitive Buyer Process (6–10 weeks) We launch the market simultaneously to a curated list of qualified buyers, manage NDAs and CIM distribution, conduct management presentations, and collect Indications of Interest. The competitive structure of this phase is what produces the price. Buyers know they are in a process. They know their bid is being compared. That structural reality is the largest single driver of premium valuation in **first-time seller M&A support**. ### Phase 3 — LOI, Diligence, and Close (3–5 months) After IOIs are received and shortlisted, we negotiate Letters of Intent in detail — not just headline price, but working capital mechanism, deal structure, exclusivity period, escrow, and earnout terms. Once an LOI is signed, we manage the data room, coordinate with healthcare M&A counsel, defend the EBITDA bridge through Quality of Earnings, and negotiate the definitive purchase agreement to close. A typical Hendon Partners-led process runs 6–9 months from engagement to funded close. --- ## Our Buyer Network for Home Care Acquisitions A **buyer network for home care acquisitions** is only useful if it is active, qualified, and current. Buyer lists go stale quickly — platforms exit, mandates change, fund cycles end, geographies open and close. Hendon Partners maintains active dialogue with **200+ qualified home care buyers** across: - **Private equity platforms** in personal care, home health, hospice, IDD, behavioral health, ABA, pediatric home health, and private duty nursing - **Strategic acquirers** including national multi-service operators and publicly traded providers - **Family offices and independent sponsors** focused on healthcare services - **Search funds and operator-led acquirers** for smaller mid-market deals For each engagement, we match the agency to the subset of buyers most likely to pay the highest price for that specific combination of service line, payer mix, geography, and EBITDA size. A pediatric private duty nursing agency in Texas attracts a different buyer set than a Medicare-certified home health agency in a CON state. Generic outreach destroys value. Targeted outreach captures it. --- ## Healthcare and Home Care Deal Expertise Home care M&A is not generic M&A with healthcare branding. The technical complexity is real, and it is where unprepared sellers and generalist advisors give up value. Areas where **healthcare and home care deal expertise** materially affects price and certainty: - **Payer mix valuation** — Medicare, Medicaid, MLTSS, MA, VA, private duty, commercial — each is valued differently and trades at different multiples - **CMS 80/20 rule** exposure modeling for Medicaid HCBS agencies - **CON state dynamics** — Certificate of Need transferability and impact on buyer universe - **Caregiver turnover** and its specific drag on valuation multiples - **Quality measures** — STAR ratings, HHCAHPS, CAHPS Hospice, deficiency history - **Cost report exposure** for Medicare-certified providers - **CHOW timing** for Medicare, Medicaid, and state license transfers - **Working capital adjustments** specific to home-based care receivables behavior - **Reps and warranties** language unique to healthcare regulatory exposure A generalist advisor will defer these issues to legal counsel — too late and at significant cost. A specialized advisor builds the deal structure around them from day one. --- ## Maximizing Home Care Agency Sale Value: What Actually Drives the Number Three things drive **maximizing home care agency sale value** more than any others: ### 1. EBITDA Quality, Not Just EBITDA Size Buyers do not pay for reported EBITDA. They pay for **normalized**, **defensible**, **recurring** EBITDA. The work of identifying, documenting, and defending every legitimate add-back — owner compensation above market, one-time legal expenses, non-business travel, family payroll, real estate normalization, M&A transaction costs — directly translates to enterprise value at the closing multiple. We routinely add 15–25% to reported EBITDA through proper normalization. ### 2. Competitive Tension, End to End A single bidder is not a market. Two bidders is a courtesy. **Eight to fifteen qualified bidders is a market** — and that market sets the price. The structural design of the process, not the negotiation tactics inside any single conversation, is what produces premium outcomes. ### 3. Buyer-Type Matching Strategic buyers, private equity platforms in growth mode, private equity platforms looking for tuck-ins, and standalone operators all value the same business differently. Knowing which buyer pays the most for a specific business — and structuring the process to bring that buyer to a winning bid — is craft, not luck. --- ## Who Hendon Partners Represents We focus on mid-sized, founder-led home-based care agencies preparing for their first sale. Our typical engagement profile: - **Service lines:** Personal care, home health, hospice, private duty nursing, pediatric home health, IDD, ABA/autism therapy, behavioral health - **Size:** $5M–$100M+ in revenue, $1M–$15M+ in adjusted EBITDA - **Geography:** United States - **Stage:** First-time sellers, founders, family-held businesses, multi-generational owners - **Goals:** Full sale, majority recapitalization, partial liquidity with rollover equity, succession planning We do not represent buyers. We do not run multiple competing seller processes in the same market simultaneously. Our economics and our calendar are aligned with your outcome. --- ## What to Expect From an Initial Conversation The first conversation with Hendon Partners is a confidential, no-obligation discussion focused on three questions: 1. **What is the business worth today?** A preliminary valuation range based on your normalized EBITDA, service line, payer mix, and current market multiples. 2. **What is the path to a higher number?** Specific preparation steps that would lift the valuation between today and a target close date — typically a 6–24 month horizon. 3. **Is now the right time?** Honest perspective on market conditions, buyer appetite for your specific service line, and whether your personal and financial readiness lines up with current windows. There is no obligation, no engagement, and no fee for this conversation. Most first-time sellers leave with a clearer picture of their options regardless of whether they ever choose to engage an advisor. **[Schedule a confidential conversation with Hendon Partners →](/contact-us)** --- *Hendon Partners is a sell-side only home care M&A advisory firm specializing in mid-sized, first-time sellers across personal care, home health, hospice, IDD, behavioral health, and pediatric home health. We have advised on 150+ home-based care transactions and maintain active relationships with the most acquisitive buyers in the market.* --- ## Frequently Asked Questions ### What are home care M&A advisory services? Home care M&A advisory services are specialized sell-side investment banking services that prepare a home care, home health, or hospice agency for sale, run a competitive buyer process, and negotiate the transaction from initial outreach through funded close. A specialized advisor manages valuation, the Confidential Information Memorandum (CIM), buyer outreach, due diligence, and closing — typically improving proceeds by 20–40% versus an unrepresented sale. ### Why do first-time home care sellers need an M&A advisor? First-time sellers will run their sale process once. The buyers they negotiate with — private equity platforms, strategic acquirers, and national operators — have completed dozens or hundreds of acquisitions. A specialized advisor levels that experience gap, prevents the value-destroying mistakes most common in first sales, and creates competitive tension that drives valuation higher. ### What size home care agency benefits most from M&A advisory? Mid-sized home care, home health, and hospice agencies generating $1M–$10M+ in adjusted EBITDA see the largest absolute gains from advisory representation. At this size, buyer competition is deepest, valuation multiples are most variable, and the difference between a poorly run and well-run process can equal millions of dollars. ### How does Hendon Partners' buyer network help maximize sale value? Hendon Partners maintains active dialogue with 200+ qualified home care buyers — private equity platforms, strategic operators, family offices, and search funds. We match each seller to the buyers most likely to pay a premium for that specific business, and run a structured competitive process that creates leverage at every stage. ### What does a home care M&A advisor cost? Sell-side M&A advisory in home care is typically structured as a small monthly retainer plus a success fee of 3–6% of transaction value at close. The retainer is usually credited against the success fee. Specialized advisors consistently deliver outcomes that exceed their fees several times over through higher valuations and better deal terms.